ReviewBlood advances2019
Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval.
Adam Yuh Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled itcites it
ReviewBlood advances2019
Adam Yuh Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.